URGING THE HAWAII STATE DIRECTOR OF HEALTH TO ISSUE A STATEWIDE ORDER TO ALLOW FOR THE SALE AND PURCHASE OF NEBULIZED BUDESONIDE WITHOUT A PRESCRIPTION OR CONSULTATION WITH A HEALTHCARE PROVIDER.
This bill is a House resolution urging the Hawaii State Director of Health to allow the sale and purchase of nebulized budesonide without a prescription. It also requests that the Board of Pharmacy adopt rules ensuring proper labeling and usage instructions are provided to consumers. The resolution cites various international studies and health guidelines supporting the use of budesonide for respiratory conditions, particularly in relation to COVID-19 treatment. The measure does not change any laws directly but asks state health officials to issue an order making the medication and nebulizer machines more accessible to the public.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2026
Committee Review
Floor Vote
Governor
Introduced Mar 16, 2026
Last action Mar 18, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Mar 18, 2026
Committee
Referred to HLT, CPC, referral sheet 19
lower
Mar 16, 2026
Introduced
Offered
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
David Alcos
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 126
Scope: HI
Hi! I can help you understand HR 126. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline